Salarius Pharmaceuticals, Inc. Revenue 2015–2022
Salarius Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2015 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Salarius Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2023 was 0.
- Salarius Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2023 was 0, a 100.00% decrease year-over-year.
- Salarius Pharmaceuticals, Inc. annual revenue for 2022 was 0, a 100.00% decrease from 2021.
- Salarius Pharmaceuticals, Inc. annual revenue for 2021 was 1.8 M, a 64.84% decrease from 2020.
- Salarius Pharmaceuticals, Inc. annual revenue for 2020 was 5.2 M, a 51.03% increase from 2019.
- Salarius Pharmaceuticals, Inc. annual revenue for 2019 was 3.5 M.
Salarius Pharmaceuticals, Inc. (DCOY) — Frequently Asked Questions
Salarius Pharmaceuticals, Inc. (DCOY) is a publicly traded US company. It has a market capitalization of $12M. Explore DCOY's stock price, financial statements, earnings history, margins and key ratios below.
What is Salarius Pharmaceuticals, Inc.'s market cap?
Salarius Pharmaceuticals, Inc. (DCOY) has a market capitalization of $12M.
What is the DCOY stock price?
DCOY trades at $5.59 (+1.45% on the day).
Is DCOY profitable?
In fiscal 2022, Salarius Pharmaceuticals, Inc. reported net income of -$32M.